Shuttle Pharmaceuticals Holdings, Inc. SHPH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.89M | 1.95M | 2.28M | 1.32M | 2.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.95M | 2.22M | 2.79M | 2.27M | 3.91M |
| Operating Income | -3.95M | -2.22M | -2.79M | -2.27M | -3.91M |
| Income Before Tax | -3.15M | -2.15M | -2.61M | -2.35M | -3.71M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.15M | -2.15M | -2.61M | -2.35M | -3.71M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.15M | -2.15M | -2.61M | -2.35M | -3.71M |
| EBIT | -3.95M | -2.22M | -2.79M | -2.27M | -3.91M |
| EBITDA | -2.68M | -2.22M | -2.50M | -2.27M | -3.91M |
| EPS Basic | -3.10 | -4.28 | -9.44 | -10.51 | -32.91 |
| Normalized Basic EPS | -2.40 | -2.67 | -6.67 | -6.57 | -20.57 |
| EPS Diluted | -3.10 | -4.28 | -9.46 | -10.51 | -32.91 |
| Normalized Diluted EPS | -2.40 | -2.67 | -6.67 | -6.57 | -20.57 |
| Average Basic Shares Outstanding | 1.02M | 503.20K | 277.00K | 223.40K | 112.60K |
| Average Diluted Shares Outstanding | 1.02M | 503.20K | 277.00K | 223.40K | 112.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |